The importance of precision medicine for cancer patients

Every cancer case is unique. That means that even if two patients have the same diagnosis, the molecular make-up of their tumor will be distinct, and they would probably respond in a different manner to the same therapy. That’s why, precision medicine should play a key role in cancer patient management.OncoDNA has established during the last years a big evidence-based database and developed different tumor profiling solutions based on solid biopsies, liquid biopsies or a combination of both. According to the results of the patient profiling, we can predict sensitivity or resistance to approved or in development targeted therapies, chemotherapies, hormonal therapies and immunotherapies. Moreover, thanks to the use of liquid biopsies we are also able to monitor therapy efficacy and tumor relapse.